Am J Perinatol 2013; 30(10): 833-838
DOI: 10.1055/s-0033-1333674
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Changes in Care Associated with the Introduction of a Postpartum Hemorrhage Patient Safety Program

Justin R. Lappen
1   Department of Obstetrics and Gynecology, University Hospitals, Case Western Reserve University School of Medicine, Cleveland, Ohio
,
Dominika Seidman
2   Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Carol Burke
3   Northwestern Memorial Hospital, Chicago, Illinois
,
Kris Goetz
3   Northwestern Memorial Hospital, Chicago, Illinois
,
William A. Grobman
2   Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

03 November 2012

13 November 2012

Publication Date:
28 January 2013 (online)

Preview

Abstract

Objective To determine whether the introduction of a postpartum hemorrhage (PPH) patient safety program was associated with changes in patient care or outcomes.

Study Design A multipronged patient safety program regarding PPH was instituted at a tertiary care maternity hospital. Patient care and outcomes were assessed for 6 months prior to (period A) and 6 months after (period B) program institution.

Results In all, 278 and 341 women were diagnosed with PPH during periods A and B, respectively. Women who had a PPH after the program were more likely to receive more than one dose of prostaglandin F2 α (24% versus 9%, p = 0.01) and more than one type of uterotonic (34% versus 25%, p = 0.02) and to have a B-lynch suture placed (9.4% versus 4.7%, p = 0.03). The frequency of blood transfusion, hysterectomy, and intensive care unit admission were similar between periods.

Conclusion Introduction of a PPH safety program resulted in several indications of a more quickly escalated response.

Note

Presented at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, February 9, 2012, Dallas, Texas.